Global Molecular Diagnostics Market: Opportunities & Future Forecast
Renub Research report titled “Global Molecular Diagnostics Market: Opportunities & Future Forecast” analysis the global molecular diagnostics market. This research report provides the global molecular diagnostics industry past present and future scenario. The specific clinical segments like Infectious Disease Testing Market, ID/forensics Market, Tissue Typing Market, Oncology Market, Food Testing Market, Genetic Testing Market and Pharmacogenomics Market past, present and future scenario has been analyzed in this report. The report provides separate comprehensive past, present and future forecast of molecular diagnostics market on country level as well. Countries covered in the report are: US, Europe and India.
Market Overview
Based on its exceptional ability to accurately detect the primary cause of disease, molecular diagnostics has emerged as the fastest growing segment of the in vitro diagnostics (IVD) industry. Growing with a CAGR of 19 percent global molecular diagnostics market is expected to reach US$ 7 Billion by 2011. The infectious disease was having the biggest market share of 70 percent but gradually its share will decline to 50 percent. The future growth is expected to come from Oncology Testing, Genetic Testing and Pharmacogenomics Testing.
Geographically, the US and European markets are the most advanced in terms of adoption of molecular testing and make up the majority of the existing market. However Indian molecular diagnostics market is also catching up fast and future growth is expected from these markets when US and European market will mature. Key player wise molecular diagnostics market is dominated by big companies such as Roche Diagnostics, Gen-Probe, Siemens Healthcare Diagnostics Inc. and Abbott Laboratories which are active in every segment of the clinical diagnostics market. They have broader product portfolios, which can address the needs of any kind of clinical laboratories. However, their leadership is likely to be challenged by the emergence of a new breed of players who target growth areas such as oncology and pharmacogenomics.
Report Forecasts
Research Highlights
Key Company Profiles
This section provides business overview and key financial information of the companies listed below: Roche Holding Ltd, Abbott, Bayer AG, QIAGEN N.V., Gen-Probe, Becton Dickinson and Company, bioMérieux, Chiron, Myriad Genetics, Inc., Celera.
Data Sources
Information and data in this report has been collected from various printable and non-printable sources like Magazines, Newspapers, Trade Journals, White papers, Online paid databases, News websites Government Agencies and Trade associations.
Market Overview
Based on its exceptional ability to accurately detect the primary cause of disease, molecular diagnostics has emerged as the fastest growing segment of the in vitro diagnostics (IVD) industry. Growing with a CAGR of 19 percent global molecular diagnostics market is expected to reach US$ 7 Billion by 2011. The infectious disease was having the biggest market share of 70 percent but gradually its share will decline to 50 percent. The future growth is expected to come from Oncology Testing, Genetic Testing and Pharmacogenomics Testing.
Geographically, the US and European markets are the most advanced in terms of adoption of molecular testing and make up the majority of the existing market. However Indian molecular diagnostics market is also catching up fast and future growth is expected from these markets when US and European market will mature. Key player wise molecular diagnostics market is dominated by big companies such as Roche Diagnostics, Gen-Probe, Siemens Healthcare Diagnostics Inc. and Abbott Laboratories which are active in every segment of the clinical diagnostics market. They have broader product portfolios, which can address the needs of any kind of clinical laboratories. However, their leadership is likely to be challenged by the emergence of a new breed of players who target growth areas such as oncology and pharmacogenomics.
Report Forecasts
- What will be the global molecular diagnostics market in 2011?
- What will be the molecular diagnostics market of Europe, India in 2011 and US in 2012?
- What will be the market of Infectious Disease Testing in 2011?
- What will be the market of ID/forensics Market in 2011?
- What will be the market of Tissue Typing Market in 2011?
- What will be the market of Oncology Market in 2011?
- What will be the market of Food Testing Market in 2011?
- What will be the market of Genetic Testing Market in 2011?
- What will be the market of Pharmacogenomics Market in 2011?
Research Highlights
- Global molecular diagnostics market is expected to reach the figure of US$ 7 Billion by 2011.
- US molecular diagnostics market is expected to cross the US$ 4 Billion by 2012.
- European molecular diagnostics market is expected to cross US 1 Billion by 2012.
- India molecular diagnostics market is expected to cross INR 1 Billion by 2011.
- United States and Europe together holds more than 75 percent of molecular diagnostics market in 2008.
- Infectious disease has the highest percentage of market share in 2008 but its share will decline in future.
- Genetic testing is having the second highest market shares in the molecular diagnostics market segment.
- Future prospectus for India molecular diagnostics market an analysis.
- India molecular diagnostics instruments & reagents market for 2007 & 2008
Key Company Profiles
This section provides business overview and key financial information of the companies listed below: Roche Holding Ltd, Abbott, Bayer AG, QIAGEN N.V., Gen-Probe, Becton Dickinson and Company, bioMérieux, Chiron, Myriad Genetics, Inc., Celera.
Data Sources
Information and data in this report has been collected from various printable and non-printable sources like Magazines, Newspapers, Trade Journals, White papers, Online paid databases, News websites Government Agencies and Trade associations.
1. EXECUTIVE SUMMARY
2. GLOBAL – MOLECULAR DIAGNOSTICS MARKET
2.1 Past & Present Overview
2.1.1 Future Forecast
3. GEOGRAPHICAL DISTRIBUTION - MOLECULAR DIAGNOSTICS MARKET (PAST, PRESENT & FUTURE FORECAST)
3.1 US Molecular Diagnostics Market
3.2 Europe Molecular Diagnostics Market
3.3 India Molecular Diagnostics Market
4. GLOBAL - MOLECULAR DIAGNOSTICS TEST MARKET (PAST, PRESENT & FUTURE FORECAST)
4.1 Infectious Disease Testing Market
4.2 ID/forensics Market
4.3 Tissue Typing Market
4.4 Oncology Market
4.5 Food Testing Market
4.6 Genetic Testing Market
4.7 Pharmacogenomics Market
5. OPPORTUNITIES & CHALLENGES
5.1 Opportunities
5.1.1 Genomic Medicine and Personalized Medicine
5.1.2 Adoption of Automated Platforms
5.1.3 Growing Interests towards Companion Diagnostics
5.1.4 Market for Big Players
5.1.5 HPV Testing & Infectious Diseases
5.1.6 Intense and Growing Interest in Personalized Medicine
5.2 Challenges
5.2.1 Reimbursement
5.2.2 Shortage of Healthcare Personnel
5.2.3 Informatics
5.2.4 Privacy/Legislation
6. KEY PLAYERS
6.1 Roche Holding Ltd
6.2 Abbott
6.3 Bayer AG
6.4 QIAGEN N.V.
6.5 Gen-Probe
6.6 Becton, Dickinson and Company
6.7 bioMérieux
6.8 Chiron
6.9 Myriad Genetics, Inc.
6.10 Celera Corporation
2. GLOBAL – MOLECULAR DIAGNOSTICS MARKET
2.1 Past & Present Overview
2.1.1 Future Forecast
3. GEOGRAPHICAL DISTRIBUTION - MOLECULAR DIAGNOSTICS MARKET (PAST, PRESENT & FUTURE FORECAST)
3.1 US Molecular Diagnostics Market
3.2 Europe Molecular Diagnostics Market
3.3 India Molecular Diagnostics Market
4. GLOBAL - MOLECULAR DIAGNOSTICS TEST MARKET (PAST, PRESENT & FUTURE FORECAST)
4.1 Infectious Disease Testing Market
4.2 ID/forensics Market
4.3 Tissue Typing Market
4.4 Oncology Market
4.5 Food Testing Market
4.6 Genetic Testing Market
4.7 Pharmacogenomics Market
5. OPPORTUNITIES & CHALLENGES
5.1 Opportunities
5.1.1 Genomic Medicine and Personalized Medicine
5.1.2 Adoption of Automated Platforms
5.1.3 Growing Interests towards Companion Diagnostics
5.1.4 Market for Big Players
5.1.5 HPV Testing & Infectious Diseases
5.1.6 Intense and Growing Interest in Personalized Medicine
5.2 Challenges
5.2.1 Reimbursement
5.2.2 Shortage of Healthcare Personnel
5.2.3 Informatics
5.2.4 Privacy/Legislation
6. KEY PLAYERS
6.1 Roche Holding Ltd
6.2 Abbott
6.3 Bayer AG
6.4 QIAGEN N.V.
6.5 Gen-Probe
6.6 Becton, Dickinson and Company
6.7 bioMérieux
6.8 Chiron
6.9 Myriad Genetics, Inc.
6.10 Celera Corporation
LIST OF FIGURES:
2 1: Global – Molecular Diagnostics Market (Million US$), 2005 – 2008
2 2: Global – Forecast for Molecular Diagnostics Market (Million US$), 2009 – 2011
3 1: US - Molecular Diagnostics Market (Million US$), 2002 – 2008
3 2: US – Forecast for Molecular Diagnostics Market (Million US$), 2009 – 2012
3 3: Europe - Molecular Diagnostics Market (Million US$), 2004 – 2008
3 4: Europe – Forecast for Molecular Diagnostics Market (Million US$), 2009 – 2011
3 5: India - Molecular Diagnostics Market (Million INR), 2006 – 2008E
3 6: India – Forecast for Molecular Diagnostics Market (Million INR), 2009 – 2011
3 7: India – Molecular Diagnostics Instruments & Reagents Market (Million INR), 2007
3 8: India – Molecular Diagnostics Instruments & Reagents Market (Million INR), 2008
4 1: Global Molecular Test Sales – Infectious Disease, ID/Forensics, Tissue Typing, Oncology, Food Testing, Genetic Testing & Pharmacogenomics (Market, in Percent), 2005 – 2008
4 2: Global Molecular Test Sales – Infectious Disease, ID/Forensics, Tissue Typing, Oncology, Food Testing, Genetic Testing & Pharmacogenomics (Market, in Percent), 2009 – 2011
4 3: Global Molecular Test Sales - Infectious Diseases Testing Market (Million US$), 2005 – 2008
4 4: Global Molecular Test Sales – Forecast for Infectious Diseases Testing Market (Million US$), 2009 – 2011
4 5: Global Molecular Test Sales - ID/forensics Market (Million US$), 2005 – 2008
4 6: Global Molecular Test Sales – Forecast for ID/forensics Market (Million US$), 2009 – 2011
4 7: Global Molecular Test Sales - Tissue typing Market (Million US$), 2005 – 2008
4 8: Global Molecular Test Sales – Forecast for Tissue typing Market (Million US$), 2009 – 2011
4 9: Global Molecular Test Sales - Oncology Market (Million US$), 2005 – 2008
4 10: Global Molecular Test Sales – Forecast for Oncology Market (Million US$), 2009 – 2011
4 11: Global Molecular Test Sales – Food Testing Market (Million US$), 2005 – 2008
4 12: Global Molecular Test Sales – Forecast for Food Testing Market (Million US$), 2009 – 2011
4 13: Global Molecular Test Sales – Genetic Testing Market (Million US$), 2007 – 2011
4 14: Global Molecular Test Sales – Pharmacogenomics Market (Million US$), 2005 – 2008
4 15: Global Molecular Test Sales – Pharmacogenomics Market (Million US$), 2009 – 2012
5 1: Global - Molecular Diagnostics Market Segments of Companies
2 1: Global – Molecular Diagnostics Market (Million US$), 2005 – 2008
2 2: Global – Forecast for Molecular Diagnostics Market (Million US$), 2009 – 2011
3 1: US - Molecular Diagnostics Market (Million US$), 2002 – 2008
3 2: US – Forecast for Molecular Diagnostics Market (Million US$), 2009 – 2012
3 3: Europe - Molecular Diagnostics Market (Million US$), 2004 – 2008
3 4: Europe – Forecast for Molecular Diagnostics Market (Million US$), 2009 – 2011
3 5: India - Molecular Diagnostics Market (Million INR), 2006 – 2008E
3 6: India – Forecast for Molecular Diagnostics Market (Million INR), 2009 – 2011
3 7: India – Molecular Diagnostics Instruments & Reagents Market (Million INR), 2007
3 8: India – Molecular Diagnostics Instruments & Reagents Market (Million INR), 2008
4 1: Global Molecular Test Sales – Infectious Disease, ID/Forensics, Tissue Typing, Oncology, Food Testing, Genetic Testing & Pharmacogenomics (Market, in Percent), 2005 – 2008
4 2: Global Molecular Test Sales – Infectious Disease, ID/Forensics, Tissue Typing, Oncology, Food Testing, Genetic Testing & Pharmacogenomics (Market, in Percent), 2009 – 2011
4 3: Global Molecular Test Sales - Infectious Diseases Testing Market (Million US$), 2005 – 2008
4 4: Global Molecular Test Sales – Forecast for Infectious Diseases Testing Market (Million US$), 2009 – 2011
4 5: Global Molecular Test Sales - ID/forensics Market (Million US$), 2005 – 2008
4 6: Global Molecular Test Sales – Forecast for ID/forensics Market (Million US$), 2009 – 2011
4 7: Global Molecular Test Sales - Tissue typing Market (Million US$), 2005 – 2008
4 8: Global Molecular Test Sales – Forecast for Tissue typing Market (Million US$), 2009 – 2011
4 9: Global Molecular Test Sales - Oncology Market (Million US$), 2005 – 2008
4 10: Global Molecular Test Sales – Forecast for Oncology Market (Million US$), 2009 – 2011
4 11: Global Molecular Test Sales – Food Testing Market (Million US$), 2005 – 2008
4 12: Global Molecular Test Sales – Forecast for Food Testing Market (Million US$), 2009 – 2011
4 13: Global Molecular Test Sales – Genetic Testing Market (Million US$), 2007 – 2011
4 14: Global Molecular Test Sales – Pharmacogenomics Market (Million US$), 2005 – 2008
4 15: Global Molecular Test Sales – Pharmacogenomics Market (Million US$), 2009 – 2012
5 1: Global - Molecular Diagnostics Market Segments of Companies
LIST OF TABLES:
6 1: Roche Holding Ltd - Key Financials (Million USD), 2006 – 2008
6 2: Abbott - Key Financials (Million USD), 2006 – 2008
6 3: Bayer AG - Key Financials (Million USD), 2006 – 2008
6 4: QIAGEN N.V. - Key Financials (Million USD), 2006 – 2008
6 5: Gen-Probe - Key Financials (Million USD), 2006 – 2008
6 6: Becton, Dickinson and Company - Key Financials (Million USD), 2006 – 2008
6 7: bioMérieux - Key Financials (Million USD), 2006 – 2008
6 8: Myriad Genetics, Inc. - Key Financials (Million USD), 2006 – 2008
6 9: Celera Corporation - Key Financials (Million USD), 2006 – 2008
6 1: Roche Holding Ltd - Key Financials (Million USD), 2006 – 2008
6 2: Abbott - Key Financials (Million USD), 2006 – 2008
6 3: Bayer AG - Key Financials (Million USD), 2006 – 2008
6 4: QIAGEN N.V. - Key Financials (Million USD), 2006 – 2008
6 5: Gen-Probe - Key Financials (Million USD), 2006 – 2008
6 6: Becton, Dickinson and Company - Key Financials (Million USD), 2006 – 2008
6 7: bioMérieux - Key Financials (Million USD), 2006 – 2008
6 8: Myriad Genetics, Inc. - Key Financials (Million USD), 2006 – 2008
6 9: Celera Corporation - Key Financials (Million USD), 2006 – 2008
